How to Gain From David Einhorn's Pain

Related Link: 

David Einhorn’s hedge-fund firm has posted big losses. Another firm he controls may offer investors a value play on any comeback.

Investors Betting on More ECB Stimulus

Related Link: 

Six months after the European Central Bank launched its blockbuster bond-buying program to rouse the region’s economy, some investors are betting that authorities will crank stimulus efforts even higher.

China's Economic Woes Echo Across Asia

Related Link: 

Evidence is increasing that China’s economic slowdown is rippling across Asia, with a startling plunge in South Korean exports and softening manufacturing in Malaysia and Vietnam.

India Says New Tax Won't Apply to Foreign Institutional Investors

Related Link: 

India said it wouldn’t apply a new tax to international portfolio investors, hoping to calm concerns about the country amid global market volatility.

Evergrande's Health Needs a Second Opinion

Related Link: 

Chinese developer Evergrande’s performance may not be as grand as it seems.

Dealing With 'Daddy Track': Men Face Challenges Going Part Time

Related Link: 

As women make strides in the workplace and men shoulder more caregiving duties at home, few fathers have workplace flexibility figured out.

Amgen Finds Data Falsified in Grizzly Bear Study

Related Link: 

A scientific paper that had captured widespread attention because its subjects were massive grizzly bears has been retracted, after one of the authors was said to have manipulated some of the data.

China Boosts Efforts to Keep Money at Home

Related Link: 

China is imposing new controls to prevent too much money from leaving the country, with lenders beefing up internal checks on foreign-exchange conversions and regulators aiming to rein in illegal money-transfer agents.

Stocks Tumble on Weak Chinese Data

Related Link: 

U.S. stocks tumbled Tuesday after weak manufacturing data in China fueled investors’ worries about the world’s second-largest economy.

Bayer Separates Material Science Business

Related Link: 

German pharmaceuticals group Bayer has moved a step closer to floating its $12.38 billion specialty chemicals business by legally and economically separating the unit, now named Covestro.

Syndicate content